Announcements Trials
Browse Landscape

Phase

Phase 2 20Phase 1 20Phase 3 8Phase 1/2 7Phase 2/3 3Phase 4 2Phase NA 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Carcinoma, Hepatocellular 9Liver Neoplasms 2Portal Vein Tumor Thrombus 1Neoplasms 1Neoplasm Metastasis 1Carcinoma, Renal Cell 1

Interventions

Radiofrequency Ablation 4gadolinium ethoxybenzyl DTPA 2atezolizumab 2Sorafenib 2Oxaliplatin 2Fluorouracil 2Dexmedetomidine 2Bevacizumab 2voxilaprevir 1velpatasvir 1huachansu 1entecavir 1Tobacco Use Cessation Devices 1Tinzaparin 1Telbivudine 1Technetium Tc 99m Aggregated Albumin 1Sofosbuvir 1Sevoflurane 1Ribavirin 1Radionuclide Generators 1Psychiatric Rehabilitation 1Propofol 1Pregabalin 1Polymerase Chain Reaction 1Nivolumab 1Neuroleptanalgesia 1Lamivudine 1Immunotherapy 1Gene Expression Profiling 1Galactose 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Liver Neoplasms × Sorafenib × Clear all
NCT01849588 2017-04-19

HCV-RNA Kinetics During Sorafenib for Hepatocellular Carcinoma (HCC)

Massachusetts General Hospital

Phase 4 Terminated
3 enrolled 5 charts
Gastrointestinal

Liver Neoplasms

NCT01203787 2015-03-05

Sorafenib Dose Ramp-Up in Hepatocellular Carcinoma (HCC)

University of Florida

Phase 4 Completed
120 enrolled 14 charts
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡